Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis (SSc).

fibrosis clinical trials

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 26 December 2013 - 07:49 AM

Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis (SSc).

 

There is a high unmet clinical need for effective antifibrotic therapies in systemic sclerosis (SSc), and in parallel a rapid development in the identification of potential molecular targets in preclinical research. This could increase the possibility to develop successful drugs against the fibrotic manifestations of SSc. PubMed, Curr Opin Rheumatol. 2013 Nov;25(6):679-85. (Also see: What is Fibrosis? and Scleroderma Clinical Trials)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)